IOB : 0IRF.IL
-$0.04 (-1.01%)
IOB
Werner Lanthaler
Drug Manufacturers - Specialty & Generic
Healthcare
0IRF.IL
5067
DE
EUR
0.55
1.68
1.60
0.92
0.00
$788.37M
0.82
0.88
-14.47
-0.24
-$0.58
-$103.52M
-26.02%
-24.04%
-24.55%
-11.82%
-3.18
0.04
0.04
1/5
6 Analysts
%
0.01
4/9
$287.9M
$1.64B
$940.19M
-$136.74M
No key metrics data available.
| Name | Title |
|---|---|
| Laetitia Rouxel | Chief Financial Officer & Member of Management Board |
| Monika Conradt | Global Head of HR |
| Werner Lanthaler | Chairman of Management Board & Chief Executive Officer |
| Gabriele Hansen | Sr. VP & Head of Global Corp. Communications & Marketing |
| Volker Braun | Sr. VP and Global Head of Investor Relations & ESG |
| Anja Bosler | Principal Accounting Officer and Sr. VP of Group Accounting |
| Christian Dargel | EVice President Global Head of Legal & Compliance |
| Cord Dohrmann | Chief Scientific Officer & Member of Management Board |
| Matthias Evers | Chief Bus. Officer & Member of Management Board |
| Craig Johnstone | Chief Operating Officer & Member of Management Board |
No votes yet today — be the first to share your view!
About Evotec SE (IOB:0IRF.IL) Stock
Evotec SE operates as a global collaborative partner for the pharmaceutical and biotechnology industries, focusing on drug discovery and development. The firm is actively engaged in advancing medicinal products spanning a diverse range of therapeutic areas. These include metabolic conditions such as diabetes and its related complications, along with fibrosis, infectious diseases, central nervous system disorders, oncology, pain and inflammation, immunology, rare diseases, respiratory ailments, and women's health. The company maintains numerous partnership agreements with prominent entities including Bayer AG, Lilly, Chinook Therapeutics, Novo Nordisk A/S, Galapagos, Pfizer Inc., CONBA Pharmaceutical Co., Ltd., Bristol Myers Squibb Company, Zhejiang JingXin Pharmaceutical Co., Ltd, Kazia Th ... erapeutics, Apeiron Biologics, and Takeda Pharmaceuticals. Established in 1993, and headquartered in Hamburg, Germany, Evotec SE adopted its present name in April 2019, previously being known as Evotec AG.
Frequently Asked Questions
What is the current Evotec SE (0IRF.IL) stock price?
Evotec SE(IOB:0IRF.IL) stock price is $3.429 in the last trading session. During the trading session, 0IRF.IL stock reached the peak price of $7.812 while $3.178 was the lowest point it dropped to. The percentage change in 0IRF.IL stock occurred in the recent session was --1.01% while the dollar amount for the price change in 0IRF.IL stock was -$0.04.
0IRF.IL's industry and sector of operation?
The IOB listed 0IRF.IL is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of 0IRF.IL?
Laetitia Rouxel
| Chief Financial Officer & Member of Management Board
Monika Conradt
| Global Head of HR
Werner Lanthaler
| Chairman of Management Board & Chief Executive Officer
Gabriele Hansen
| Sr. VP & Head of Global Corp. Communications & Marketing
Volker Braun
| Sr. VP and Global Head of Investor Relations & ESG
How many employees does 0IRF.IL have?
Number of 0IRF.IL employees currently stands at 5067. 0IRF.IL operates from Essener Bogen 7, Hamburg, HA 22419, DE.
Link for 0IRF.IL official website?
Official Website of 0IRF.IL is: https://www.evotec.com
How do I contact 0IRF.IL?
0IRF.IL could be contacted at phone #49 40 560 81 0 and can also be accessed through its website. 0IRF.IL operates from Essener Bogen 7, Hamburg, HA 22419, DE.
How many shares of 0IRF.IL are traded daily?
The average number of 0IRF.IL shares traded daily for last 3 months was 61.35K.
What is the market cap of 0IRF.IL currently?
The market value of 0IRF.IL currently stands at $607.57M with its latest stock price at $3.429